Clinical Trial Site

Genova 16147

2 studies enrolling now · 5 studies all time

What they study most

ANCA-Associated Vasculitis, Advanced Breast Cancer, Atypical Hemolytic-Uremic Syndrome, Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma, Metastatic Breast Cancer, RTT, Rett Syndrome, Seizure in Participants With Dravet Syndrome, Seizure in Participants With Lennox-Gastaut Syndrome, Seizure in Participants With Tuberous Sclerosis Complex

Studies at this site

• OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• Atypical Hemolytic-Uremic Syndrome (aHUS) Registry — Recruiting now
• Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures — Stopped early
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome — Stopped early